Cystatin F acts as a mediator of immune suppression in glioblastoma.
Emanuela SenjorMilica Perišić NanutBarbara BreznikAna MitrovićJernej MlakarAna RotterAndrej PorčnikTamara Lah TurnšekJanko KosPublished in: Cellular oncology (Dordrecht) (2021)
Our data implicate cystatin F as a mediator of immune suppression in glioblastoma. Increased cystatin F mRNA and protein levels in immune, glioblastoma and glioblastoma stem-like cells or trans internalized cystatin F may have an impact on decreased susceptibility of glioblastoma cells to NK cytotoxicity.